Market announcements

August 10, 2022

Notice of deferral of FDA consideration of enforcement discretion

The a2 Milk Company (a2MC, the Company) wishes to advise that earlier today it received notification from the US Food and Drug Administration (FDA) that, at this time, the FDA is deferring further consideration of the Company’s request for enforcement discretion to import infant milk formula (IMF) products into the US.
The Company has also subsequently been advised by the International Dairy Foods Association (IDFA) that equivalent letters have been sent to all pending enforcement discretion applicants, indicating that the FDA is deferring any further review at this time of all pending applications.

Authorised for release by

David Bortolussi
Managing Director and Chief Executive Officer
The a2 Milk Company Limited

A PDF of this release can be found here.

Copyright © 2022 The a2 Milk Company Limited

a2 Milk™ is a brand of A1 protein-free milk from The a2 Milk Company Limited

*A1 and A2 proteins refer to A1 and A2 beta-casein protein types